| Lynnette Renee Reville, MA, CCC-A | |
|
1325 South Apollo, Melbourne, FL 32901 | |
| (321) 508-6455 | |
| Not Available |
| Full Name | Lynnette Renee Reville |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 37 Years |
| Location | 1325 South Apollo, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316110216 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AY000498 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmh Physician Services Llc | 3779551445 | 108 |
News Archive
Critically ill patients in hospital intensive care units (ICUs) are routinely prescribed acid-suppressive medications to reduce their risk of developing stress ulcers and gastrointestinal bleeding, both of which can result from being in a stressful environment and from being intubated. Over the years, this routine practice has often been extended to patients outside the ICU, despite a lack of evidence that this population is at significant risk of these complications.
States starting to turn the corner on their Great Recession budget woes are taking the cautious approach, socking away millions of dollars in rainy day funds rather than restoring spending for education, health care and social services. At least 21 states, including Arizona, Michigan and Ohio, are putting parts of their surpluses into reserves.
Algea Therapies, a division of Globus Medical Inc. (NYSE: GMED), committed to finding innovative, minimally invasive solutions that treat pain and restore quality of life, today announced the launch of the SHIELD™ Vertebral Compression Fracture (VCF) System, a next generation fracture management and vertebral augmentation platform for patients with vertebral compression fractures.
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
› Verified 8 days ago
| Provider Name | Cmh Physician Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194760645 PECOS PAC ID: 3779551445 Enrollment ID: O20040921000171 |
News Archive
Critically ill patients in hospital intensive care units (ICUs) are routinely prescribed acid-suppressive medications to reduce their risk of developing stress ulcers and gastrointestinal bleeding, both of which can result from being in a stressful environment and from being intubated. Over the years, this routine practice has often been extended to patients outside the ICU, despite a lack of evidence that this population is at significant risk of these complications.
States starting to turn the corner on their Great Recession budget woes are taking the cautious approach, socking away millions of dollars in rainy day funds rather than restoring spending for education, health care and social services. At least 21 states, including Arizona, Michigan and Ohio, are putting parts of their surpluses into reserves.
Algea Therapies, a division of Globus Medical Inc. (NYSE: GMED), committed to finding innovative, minimally invasive solutions that treat pain and restore quality of life, today announced the launch of the SHIELD™ Vertebral Compression Fracture (VCF) System, a next generation fracture management and vertebral augmentation platform for patients with vertebral compression fractures.
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lynnette Renee Reville, MA, CCC-A 1325 S.apollo, Dr Blenda Dickenson, Melbourne, FL 32901 Ph: () - | Lynnette Renee Reville, MA, CCC-A 1325 South Apollo, Melbourne, FL 32901 Ph: (321) 508-6455 |
News Archive
Critically ill patients in hospital intensive care units (ICUs) are routinely prescribed acid-suppressive medications to reduce their risk of developing stress ulcers and gastrointestinal bleeding, both of which can result from being in a stressful environment and from being intubated. Over the years, this routine practice has often been extended to patients outside the ICU, despite a lack of evidence that this population is at significant risk of these complications.
States starting to turn the corner on their Great Recession budget woes are taking the cautious approach, socking away millions of dollars in rainy day funds rather than restoring spending for education, health care and social services. At least 21 states, including Arizona, Michigan and Ohio, are putting parts of their surpluses into reserves.
Algea Therapies, a division of Globus Medical Inc. (NYSE: GMED), committed to finding innovative, minimally invasive solutions that treat pain and restore quality of life, today announced the launch of the SHIELD™ Vertebral Compression Fracture (VCF) System, a next generation fracture management and vertebral augmentation platform for patients with vertebral compression fractures.
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
› Verified 8 days ago
Space Coast Hearing And Balance, Inc. Audiologist Medicare: Medicare Enrolled Practice Location: 1344 S Apollo Blvd Ste 301, Melbourne, FL 32901 Phone: 321-309-2806 Fax: 321-308-4020 | |
Susan B Blauel, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1223 Gateway Dr, Melbourne, FL 32901 Phone: 321-984-3885 Fax: 321-984-8483 | |
Dr. Sara Gaffney, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr, Melbourne, FL 32901 Phone: 321-725-4500 | |
Dr. Catherine Cowan-oberbeck, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 7777 N Wickham Rd, Ste 21, Melbourne, FL 32940 Phone: 321-752-4552 | |
Angela N Pinson, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Drive, Suite 1e, Melbourne, FL 32901 Phone: 321-725-4500 Fax: 321-984-8483 | |
Susan R Marek, AU.D., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1314 Pine St, Melbourne, FL 32901 Phone: 321-802-6697 |